Valuation: Photocure ASA

Market Cap 1.58B 160M 140M 128M 120M 227M 15.24B 231M 1.55B 599M 7.48B 601M 588M 25.76B P/E 2026 *
17.2x
P/E 2027 * 35.1x
Enterprise Value 1.33B 136M 118M 109M 101M 192M 12.9B 195M 1.31B 507M 6.33B 509M 498M 21.8B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.98x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+1.89%
1 week-1.00%
Current month-0.17%
1 month-1.00%
3 months-0.84%
6 months-17.66%
Current year-17.09%
1 week 57.6
Extreme 57.6
61.8
1 month 56.2
Extreme 56.2
63.5
Current year 55.2
Extreme 55.2
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 31/10/2018
Chief Tech/Sci/R&D Officer - 31/07/2021
Human Resources Officer - 31/01/2021
Director TitleAgeSince
Director/Board Member - 31/12/2021
Chairman - 26/09/2023
Director/Board Member - 22/05/2024
Date Insider Type Main position Quantity % Market Cap.
01/04/25BuyCompany 11,355 0.0419%
01/04/25BuyCompany 8,997 0.0332%
30/03/25BuyCompany 21,105 0.0778%
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%-1.00%+6.86%+26.77% 160M
+1.86%+7.65%+55.77%+158.84% 1,082B
+3.57%+7.42%+69.09%+58.92% 633B
+3.99%+7.37%+36.87%+93.77% 461B
-1.20%-1.94%+26.41%+20.22% 339B
+4.94%+3.39%+39.92%+28.93% 301B
+2.42%+1.60%+30.06%+42.24% 292B
+2.47%+5.18%-24.80%-39.60% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+4.21%+6.00%+17.72%+70.33% 163B
Average +2.30%+3.97%+28.39%+52.89% 369.99B
Weighted average by Cap. +1.86%+5.21%+41.48%+80.22%

Financials

2026 *2027 *
Net sales 658M 66.89M 58.45M 53.67M 50.05M 94.88M 6.37B 96.48M 646M 250M 3.12B 251M 246M 10.76B 663M 67.39M 58.89M 54.08M 50.43M 95.6M 6.42B 97.22M 651M 252M 3.15B 253M 248M 10.84B
Net income 92.33M 9.39M 8.2M 7.53M 7.02M 13.31M 894M 13.54M 90.68M 35.14M 438M 35.24M 34.48M 1.51B 45M 4.57M 4M 3.67M 3.42M 6.49M 435M 6.6M 44.19M 17.13M 214M 17.18M 16.8M 736M
Net Debt -242M -24.6M -21.49M -19.74M -18.41M -34.9M -2.34B -35.48M -238M -92.1M -1.15B -92.37M -90.36M -3.96B -263M -26.7M -23.33M -21.42M -19.98M -37.88M -2.54B -38.52M -258M -99.97M -1.25B -100M -98.08M -4.3B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
02/07/26 NOK 59.20 +1.89% 17,760
01/07/26 NOK 58.10 -2.02% 55,585
30/06/26 NOK 59.30 -1.33% 19,305
29/06/26 NOK 60.10 -1.15% 53,101
26/06/26 NOK 60.80 +1.67% 13,361
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
59.20NOK
Average target price
84.00NOK
Spread / Average Target
+41.89%

Quarterly revenue - Rate of surprise